HCPCS code G0144 – Screening cytopathology thin-layer billing

Key takeaways

HCPCS code G0144 covers a thin-layer screening Pap slide read by an automated system under physician supervision, with no manual rescreening.

Average-risk Medicare beneficiaries are covered once every 24 months; high-risk beneficiaries qualify annually. Billing outside that window without an ABN triggers automatic denial.

G0144 is a screening code only. Any documented symptom or known abnormality shifts the encounter to a diagnostic pathway and makes G0144 incorrect.

Pabau, the practice management platform we build, pre-fills claims from invoices, validates them and flags any claim that needs action before submission.

HCPCS code G0144: Official descriptor and CMS definition

HCPCS code G0144 covers screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid. The CMS HCPCS Level II long descriptor finishes with “automated thin layer preparation, with screening by automated system, under physician supervision.” It contains no manual rescreening step.

Three elements in the descriptor determine whether G0144 is the correct code for a given encounter:

• Collection method: The specimen must be collected in preservative fluid (liquid-based cytology), not on a conventional glass slide.
• Preparation method: The laboratory must use automated thin-layer preparation (ThinPrep or equivalent), not conventional smear technique.
• Screening method: An automated imaging system screens the slide under physician supervision. When a cytotechnologist also rescreens the slide manually, the service is G0145, not G0144.

If any element doesn’t match — a conventional smear, a manual-only read, or an added manual rescreen — G0144 is the wrong code. The claim is then at risk of denial or audit recovery.

G0144 vs. related cytopathology codes: Key differences

G0144 sits in a family of Medicare screening cytopathology codes for thin-layer slides. Picking the wrong sibling is a frequent coding error in this family. The table compares G0144 with four related cytopathology codes by who screens the slide and whether anyone rescreens it.

G0144 vs. G0145: The two codes share the same specimen, preparation and automated screening. The difference is the manual rescreen. G0144 covers the automated read alone, and G0145 adds a manual rescreening after it. If the lab report shows a manual rescreen, bill G0145. The decision path below starts one step earlier, with whether the visit is a screening at all.

G0101 is an exam code, not a cytopathology code: G0101 covers the cervical or vaginal cancer screening pelvic and clinical breast examination. The practitioner who performs the exam bills it, while the laboratory bills G0144 for the slide. Both services can happen on the same date of service. Confirm any same-day billing rules with your MAC before submitting.

Medicare coverage and eligibility for G0144 billing

Medicare Part B covers G0144 under the preventive services benefit. Coverage frequency depends on the beneficiary’s risk classification, which the treating provider must document to support the claim. Confirm current parameters with your MAC’s LCD. Frequency rules follow current policy-year guidance and may vary by jurisdiction.

• Average-risk beneficiaries: Once every 24 months (once every two years).
• High-risk beneficiaries: Annually. High-risk status requires documented risk factors such as early onset of sexual activity, multiple sexual partners, history of STI, or other CMS-defined criteria.
• ABN requirement: If the service falls outside the covered frequency window, obtain an Advance Beneficiary Notice (ABN) from the Medicare patient before the service. Failure to obtain an ABN when it is required places the financial liability on the provider, not the patient.

MAC-specific Local Coverage Determinations (LCDs) may add requirements beyond the baseline CMS policy. The A/B MAC jurisdiction covering the practice location governs. Billing compliance requirements for preventive screenings vary by MAC, so always check the applicable LCD rather than relying on a single national reference.

Required ICD-10-CM diagnosis codes for G0144

Linking the correct ICD-10-CM code to a G0144 claim signals screening intent to the payer. A diagnostic ICD-10 code implies symptoms or a known condition. It converts the encounter from a covered preventive benefit to a diagnostic service and is a leading cause of denial.

Important: The specific ICD-10-CM codes accepted for G0144 coverage vary by MAC LCD. Some LCDs maintain a defined list of qualifying diagnosis codes. A code that isn’t on that list triggers denial, even when the procedure is clinically appropriate. Check the current LCD and the current ICD-10-CM code set, which CMS updates every year.

Documentation requirements for G0144 claims

Audit exposure for G0144 centers on two areas: a lab report that doesn’t support the billed screening method, and weak risk-classification evidence. Structured risk-assessment fields, completed at the point of care, stop those omissions before claim submission.

The medical record supporting a G0144 claim must include:

• Screening intent documentation: A note confirming the visit is a preventive screening encounter, not a response to symptoms or a known condition.
• Risk classification: The patient’s risk status (average-risk or high-risk) with supporting clinical rationale. High-risk claims require documented risk factors matching CMS or MAC LCD criteria.
• Supervising physician identity: The name of the physician supervising the laboratory’s automated screening, as the descriptor requires physician supervision.
• Specimen collection method: Confirmation that the specimen was collected in preservative fluid (liquid-based cytology).
• Laboratory methodology report: Lab documentation confirming automated thin-layer preparation and screening by an automated system under physician supervision. A report that shows a manual rescreen supports G0145 instead.
• Date of last screening: To establish that the frequency limitation has not been exceeded since the prior covered service.

Applicable modifiers for HCPCS code G0144

Most G0144 claims are submitted without modifiers. A few modifier scenarios do arise, and billing staff should know when each one applies. Confirm each against your MAC’s current guidance.

G0101 and G0144 usually go out on separate claims from separate billers, so a distinct-service modifier such as 59 is not a standard pairing. Apply one only if your MAC’s edits call for it in your billing setup.

How to bill G0144: Step-by-step claim submission

Submitting a clean claim for HCPCS code G0144 requires matching five claim elements precisely. Here is the field-by-field approach for CMS-1500 and 837P electronic submissions.

1. Procedure code (Box 24D / loop 2400 SV1): Enter G0144 for the screening slide. Don’t also report a CPT cytopathology code for the same specimen. Medicare screening Pap claims use the G-code series, while some commercial payers want CPT codes instead.
2. Diagnosis pointer (Box 24E / loop 2400 diagnosis pointer): Link to the ICD-10-CM screening code (e.g., Z12.4). The diagnosis pointer must point to a covered screening-intent code from the applicable MAC LCD.
3. Place of service (Box 24B): Report the place of service where the laboratory performed the test, not the office where the specimen was collected. Hospital outpatient claims need the revenue code the facility’s MAC requires for cytology.
4. Modifier (Box 24D / loop 2400 SV1): Add GA if an ABN is on file and frequency has been exceeded. Add any other modifier only when your MAC’s guidance calls for it.
5. Billing and supervising provider: The laboratory that performs the screening usually bills G0144 under its own NPI. The practitioner who collects the specimen and performs the exam bills separately. Confirm the billing pathway with your MAC.

The superbill documentation for the encounter should pre-populate the diagnosis and procedure codes. The claim submission team then doesn’t need to re-interpret clinical notes. Structured superbill fields for G0144 and the linked ICD-10-CM code reduce keying errors at the front end of the revenue cycle.

Reimbursement rates and fee schedule for G0144

Medicare pays G0144 under the Clinical Laboratory Fee Schedule (CLFS), not the Physician Fee Schedule, because it describes a laboratory screening service. CMS updates CLFS rates every January 1.

Rates change each year, so a static figure here would go stale. Check the current CMS Clinical Laboratory Fee Schedule file for this year’s G0144 rate before you quote or post a payment.

Medicare waives the deductible and coinsurance for a covered screening Pap test. Commercial payers negotiate their own rates for the service. Understanding medical billing workflows for laboratory services helps practices separate the lab’s line from their own from the start.

Common G0144 claim denial reasons and how to fix them

G0144 denials cluster around five patterns, and most are preventable with pre-submission checks. The denial management process for cytopathology codes starts with the denial code and its cause. Correct the root cause before resubmission.

Knowing the medical billing denial codes that accompany each rejection helps billing staff route the correction to the right team member. Claims then don’t land in a generic work queue. Read the claim adjustment reason code on each remittance before you decide whether to correct, appeal, or write off.

Screening vs. diagnostic: When G0144 does not apply

G0144 applies only when the encounter is purely preventive screening, with no symptoms, no known abnormalities, and no follow-up of a prior abnormal result. When clinical documentation reflects any of the following, the encounter shifts to a diagnostic pathway and G0144 is the wrong code.

• Symptomatic presentation: Abnormal vaginal bleeding, discharge, or pelvic pain documented as the reason for the visit.
• Follow-up of a prior abnormal Pap: The visit is a repeat test following an ASCUS, LSIL, HSIL, or other abnormal cytology result. This is a diagnostic encounter, not a screening one.
• Known diagnosis: Patient has a documented cervical condition (CIN 1, CIN 2, CIN 3, carcinoma in situ) that prompted the test.
• Post-treatment surveillance: Cytopathology performed to monitor response to treatment for a known condition.

In all four scenarios, the correct billing pathway uses CPT cytopathology codes (such as CPT 88142 or 88175 for thin-layer slides). They’re billed as diagnostic services, with ICD-10 codes reflecting the known condition or symptom. Billing G0144 in these scenarios misrepresents the clinical encounter and creates a compliance risk. It typically results in denial when the diagnosis code signals abnormality rather than screening.

The clearest documentation practice is a short statement in the encounter note: “This is a routine preventive cervical cancer screening. The patient presents without symptoms, and there is no history of abnormal cytology in the prior 24 months.” That note, combined with the Z12.4 code, anchors the claim as a screening encounter.

The coding decision itself stays with the coder. Claims management software then validates each claim and flags the ones that need a fix before submission.

How Pabau keeps G0144 screening claims clean

Most G0144 problems start before the specimen leaves the room. The risk level goes unrecorded, the last screening date sits in another system, or a symptom note turns a screening into a diagnostic visit.

Pabau keeps the screening visit on one patient record. Staff can see the patient’s screening history and recorded risk factors there before the specimen is taken.

For the practice’s own lines, such as the G0101 exam, claims management pre-fills the claim from the invoice and validates it. Any claim that needs action is flagged before it goes out as a CMS-1500 through Claim.MD.

Keep screening history and claims in one place

Pabau validates claims before submission, tracks each claim’s status and keeps screening history on the patient record. See how it works for women’s health practices in a live demo.

Book a demo

Conclusion

Every G0144 denial in this guide comes from a claim that disagrees with the record. The diagnosis code, the frequency window, the lab’s screening method and the reason for the visit all have to line up.

So read the lab report and the encounter note before you code. An automated read with no manual rescreen is G0144, and an added rescreen is G0145. A documented symptom takes the screening code off the table.

Pabau’s claims management validates each claim and flags the ones that need a fix before submission, so fewer come back as denials. To see it with your own screening workflow, book a demo.

Continue your research

Need a full guide to navigating preventive screening claim denials? Denial management in healthcare covers the end-to-end process for investigating, correcting, and resubmitting denied claims across all Medicare preventive benefits.

Need the rules your HCPCS claims have to meet? Medical billing compliance guidance explains the regulatory requirements practices must meet when submitting HCPCS claims through an electronic claims pathway.

Building a more structured superbill for OB-GYN or women’s health services? Superbill documentation best practices outlines how to structure procedure and diagnosis fields to support clean claim submission for preventive screening services.

Billing the screening exam on the same day? HCPCS code G0101 covers the pelvic and clinical breast exam the practitioner reports alongside the lab’s slide.

Did a cytotechnologist screen and rescreen the slide? HCPCS code G0143 explains the manual thin-layer code and how it differs from the automated ones.

Frequently asked questions